文献速递临床试验与 GCP流行病学与生物统计

药师护理方案管理社区药房女性非复杂性膀胱炎的有效性:一项开放标签、多中心、随机、对照、整群研究:PharmaCyst'方案

Efficacy of a pharmacist care protocol to manage uncomplicated female cystitis in community pharmacies: an open-label, multicenter, randomized, controlled, cluster study: the PharmaCyst' protocol.
PubMed 文献 · Trials · 2024-10-03

PharmaCyst'是一项在法国卢瓦尔地区开展的开放标签、多中心、整群随机对照研究,计划纳入480例18-65岁、近3天出现至少一种非复杂性尿路感染症状而到社区药房求助的女性,评估药师护理方案的有效性,主要结局采用急性膀胱炎症状评分。

要点

  • 研究评估社区药师按方案管理女性非复杂性尿路感染症状的有效性。
  • 主要结局指标为急性膀胱炎症状评分(ACSS)。
  • 计划在24个整群中招募480例患者,第3天、第10天和第3个月随访。

核心结论

  • PharmaCyst'是法国首个仅由社区药师开展的临床试验,其结果可能促成该方案的推广。

研究设计与样本

  • 开放标签、多中心、对照、整群随机研究,在法国卢瓦尔地区开展。
  • 研究计划在24个整群中招募480例患者。
  • 纳入标准为18至65岁女性,因近3天内出现至少一种非复杂性尿路感染症状(包括排尿时烧灼痛、排尿困难、尿频、尿急)而到药房求助。
  • 所有患者将在第3天、第10天和第3个月接受随访。
  • 定量数据用均数和标准差描述并用Student t检验比较,定性数据用例数和百分比描述并用卡方检验(必要时Fisher精确检验)比较。

关键数值与推荐

  • 主要目标使用急性膀胱炎症状评分(Acute Cystitis Symptom Score)评估药师护理方案的有效性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Urinary tract infections are common affections, especially for women. Difficult access to a general practitioner to obtain a prescription has led France to offer dispensing under protocol by community pharmacists. The primary objective of this study is to evaluate the effectiveness of a pharmacist care protocol provided to manage women with urinary tract infection symptoms. This objective will be assessed using the Acute Cystitis Symptom Score. METHODS: PharmaCyst' is an open-label, multicenter, controlled, cluster-randomized study conducted in the Loire region, France. Women aged between 18 and 65 years presenting to a pharmacy complaining of at least one symptom of an uncomplicated urinary tract infection present over the last 3 days (including burning pain during micturition, dysuria, pollakiuria, urgent urination) will be considered for inclusion. All patients will be contacted on day 3, 10, and month 3. A total of 480 patients need to be recruited for the 24 clusters participating in the research. The quantitative data will be described using means and standard deviations and compared using Student's t-test. The qualitative data will be described using numbers and percentages and compared using chi2 test (or Fisher's exact test if necessary). The primary and secondary outcomes analyses will consider the intention-to-treat population. DISCUSSION: PharmaCyst' is the first clinical trial conducted in France only by community pharmacists. Its results could lead to an extension of the protocol. TRIAL REGISTRATION: The protocol has been approved by the French ethics committee on 2022/12/02 and is registered under the number 49RC22_0240 on ClinicalTrials.gov.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Piraux A, Parot-Schinkel E, Hamel JF, et al. Efficacy of a pharmacist care protocol to manage uncomplicated female cystitis in community pharmacies: an open-label, multicenter, randomized, controlled, cluster study: the PharmaCyst' protocol. Trials. 2024. PMID: 39363224. doi:10.1186/s13063-024-08476-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。